IP Library Granted Patent US 9,642,825
Granted Patent B2
US 9,642,825 · App. 14/192,734 · Granted May 9, 2017

Bio-available N-acetyl creatine species and compositions thereof

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,642,825
App. No.
14/192,734
Granted
May 9, 2017
Kind
B2
Abstract

Creatine derivatives and compositions containing a bioactive form of creatine. The new chemical entity comprises an acetyl creatine, N-acyl creatines, N,N-diacyl creatines or any N-acetyl creatine species with enhanced solubility and bioavailability. Also provided by this invention are various methods for providing several beneficial effects that comprise administering compositions comprising N-acetyl creatine, N-acyl creatines, N,N-diacyl creatines or any N-acetyl creatine species to a mammalian subject, either chronically or acutely.

Claims (38)

1. A composition for delivering bio-available creatine comprising:

an N-acetyl creatine species;

a non-aqueous solvent;

a preservative;

a physical stabilizing ingredient;

one or more surfactants;

wherein the N-acetyl creatine species comprises a N-Acyl creatyl amino acid dipeptide.

2. The composition of claim 1 further comprising one or more adjuvants selected from the group consisting of nucleotide species, peptides, protein isolates, lipids, starches, carbohydrates, polyols, minerals, electrolytes, amino trace elements, colorings, flavors, artificial sweeteners, anti-oxidants, vitamins and vitamin-like isoprenoids.

3. The composition of claim 2 wherein the composition further comprises water and the composition is an aqueous solution.

4. The composition of claim 1 wherein the composition further comprises a liquid fill material comprising:

a lipophilic solvent;

a hydrophilic non-aqueous vehicle;

1% to about 5% of water;

a preservative;

a physical stabilizing ingredient; and,

one or more surfactants;

wherein the composition is provided in the form of a capsule.

5. The composition of claim 1 further comprising one or more protein isolates.

6. The composition of claim 5 further comprising one or more adjuvants selected from the group consisting of nucleotide species, peptides, lipids, starches, carbohydrates, polyols, minerals, electrolytes, amino trace elements, colorings, flavors, artificial sweeteners, anti-oxidants, vitamins and vitamin-like isoprenoids.

7. A composition for delivering bio-available creatine comprising:

an N-acetyl creatine species;

a suitable non-aqueous solvent;

a preservative;

a polymer for imparting consistency; and,

a physical stabilizing ingredient;

wherein the composition is substantially stable at room temperature, stable at 104° Fahrenheit, and stable at 39° Fahrenheit; and,

wherein the N-acetyl creatine species comprises N,N-Diacyl creatine.

8. The composition of claim 7 further comprising one or more adjuvants selected from the group consisting of nucleotide species, peptides, lipids, starches, carbohydrates, polyols, minerals, electrolytes, amino trace elements, colorings, flavors, artificial sweeteners, anti-oxidants, vitamins and vitamin-like isoprenoids.

9. The composition of claim 8 further comprising one or more penetrating enhancers and a moisturizer; wherein the composition has a gel consistency and may be topically applied to the skin as a gel.

10. The composition of claim 9 further comprising one or more penetrating enhancers and a moisturizer; wherein the composition is contained in the reservoir of a transdermal patch delivery system comprising the reservoir, a line, an adhesive and a backing.

11. The composition of claim 2 further comprising one or more natural products selected from the group consisting of dried milk products, dried soy products, dried citrus fruit juices, dried non-citrus fruit juices, and dried vegetable juices.

12. A composition for delivering bio-available creatine comprising:

an N-acetyl creatine species;

a non-aqueous solvent;

a preservative;

a physical stabilizing ingredient;

one or more surfactants;

wherein the N-Acetyl creatine species comprises a N-Acyl creatyl dipeptide aliphatic ester.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 24, 2023
From: JHO INTELLECTUAL PROPERTY HOLDINGS, LLC
To: VITAL PHARMACEUTICALS, INC.
Reel/Frame 065335/0726 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 24, 2023
From: VITAL PHARMACEUTICALS, INC.; VITAL PHARMACEUTICALS INTERNATIONAL SALES, INC.
To: ENERGY BEVERAGES LLC
Reel/Frame 065336/0001 →
NOTICE OF GRANT OF SECURITY INTEREST IN PATENTS Recorded Aug 18, 2020
From: JHO INTELLECTUAL PROPERTY HOLDINGS, LLC
To: TRUIST BANK, AS ADMINISTRATIVE AGENT
Reel/Frame 053532/0581 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 22, 2015
From: 4141 HOLDINGS, LLC; OWOC, JACK H
To: JHO INTELLECTUAL PROPERTY HOLDINGS, LLC
Reel/Frame 035474/0712 →